Read Dr. Eshaghian’s Article In Paact
ON THE HORIZON – INDIVIDUALIZED BIOMARKER DRIVEN THERAPY IN CASTRATE RESISTANT PROSTATE CANCER (CRPC) –
Welcome Dr. Shahrooz Eshaghian to Compassionate Oncology Medical Group!
Dr. Eshaghian treats general oncology and hematology, with a subspecialty in Prostate Cancer.
Please contact Maria at (310) 229-3555 or email us at info@compassionateoncology.org for more information on becoming a new patient.
You Might Also Enjoy...
ON THE HORIZON – INDIVIDUALIZED BIOMARKER DRIVEN THERAPY IN CASTRATE RESISTANT PROSTATE CANCER (CRPC) –
Dr. Eshaghian will update us on what is fact and what is fiction when treating high risk and/or metastatic PCa. Dr. Bob will update us on ‘Challenging Prostate Cancer Treatment Biases; Is Nothing Sacred?”
Watch Dr. Bob & Dr. Eshaghian’s latest lecture, titled “Our Three-Pronged Approach Protocol for treatment of high-risk metastatic and/or recurrent prostate cancer and results from hundreds of PC patients utilizing High-Dose Testosterone Replacement...
See the latest PAACT newsletter (March 2014) to read Dr. Bob’s article: “Challenging PC Treatment Biases – Is Nothing Sacred? – Part I”. This is part of a three issue series, starting with an article in the Winter 2013 issue of PAACT titled...
See the latest PAACT newsletter (Dec 2013) to read Dr. Bob’s article: “Dr. Bob’s treatments and insights regarding prostate cancer”. Click here to download a copy for free. For more information on PAACT...
Dr. Bob, Dr. Eshaghian and the COMG staff wishes all a Happy Hanukkah, Merry Christmas, and a Happy HEALTHY New Year and Year of the Horse.